BiotechTube

voclosporin

Phase 3Terminated
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adolescent Lupus Nephritis

Conditions

Adolescent Lupus Nephritis, Pediatric Lupus Nephritis

Trial Timeline

Mar 28, 2024 → Jul 4, 2025

NCT ID
NCT05962788

About voclosporin

voclosporin is a phase 3 stage product being developed by Aurinia Pharmaceuticals for Adolescent Lupus Nephritis. The current trial status is terminated. This product is registered under clinical trial identifier NCT05962788. Target conditions include Adolescent Lupus Nephritis, Pediatric Lupus Nephritis.

What happened to similar drugs?

0 of 4 similar drugs in Adolescent Lupus Nephritis were approved

Approved (0) Terminated (1) Active (3)
🔄Exenatide Once Weekly + PlaceboAstraZenecaPhase 3
🔄Placebo + IBI362Innovent BiologicsPhase 3
❌Voclosporin + Placebo Oral CapsuleAurinia PharmaceuticalsPhase 3
🔄rizatriptan benzoateOrganonPhase 3

Hype Score Breakdown

Clinical
17
Activity
0
Company
9
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT05962788Phase 3Terminated
NCT03598036Phase 2Terminated
NCT02949999Phase 1Completed
NCT02949973Phase 2Completed
NCT00258713Phase 3Completed

Competing Products

8 competing products in Adolescent Lupus Nephritis

See all competitors
ProductCompanyStageHype Score
LorcaserinEisaiPhase 1
29
RSS0343 TabellaJiangsu Hengrui MedicinePhase 2
42
Exenatide Once Weekly + PlaceboAstraZenecaPhase 3
40
Placebo + IBI362Innovent BiologicsPhase 3
47
IBI362 + IBI362 placeboInnovent BiologicsPhase 1
29
Antipsychotics, mood stabilizers, etc.Brain BiotechPre-clinical
23
Voclosporin + Placebo Oral CapsuleAurinia PharmaceuticalsPhase 3
26
rizatriptan benzoateOrganonPhase 3
34